Global Tissue Banking Market Report and Forecast 2026-2034

Study Period

2021-2034

Market (2025)

USD 5.2 Billion

Market (2034)

USD 8.79 Billion

CAGR

6.00%

Major Markets Players

Thermo Fisher Scientific Inc., Lonza Group AG, BioLife Solutions Inc., Merck KGaA, Charles River Laboratories International, Inc. and Others

*Note: Partial List Randomly Ordered

Tissue Banking Market Key Highlights

Tissue Banking Market Insights & Analysis

The Tissue Banking Market is anticipated to register a 6.00% during 2026-2034. the market size was valued at USD 5.2 Billion and is projected to reach USD 8.79 Billion by 2034.

The market is expanding steadily due to increasing organ transplant procedures and rising demand for regenerative medicine. Over 150,000 transplant procedures globally each year are creating strong demand for reliable tissue preservation solutions. Additionally, growing cases of chronic diseases such as cardiovascular and orthopedic conditions are accelerating the need for advanced tissue banking services.

Technological advancements such as cryopreservation, accounting for nearly 45% share, are improving storage efficiency and tissue viability. Increasing use of tissue samples in drug discovery and clinical research by pharmaceutical and biotechnology companies is further supporting growth. Government regulations and awareness programs promoting tissue donation are also strengthening market expansion.

Tissue Banking Market Dynamics

Key Driver:

• Rising number of organ transplants and regenerative therapies
• Growing demand for advanced tissue preservation technologies
• Increasing prevalence of chronic and orthopedic diseases

Industry Trends:

• Expansion of stem cell research and regenerative medicine
• Adoption of advanced cryopreservation and vitrification techniques
• Growing use of tissue samples in drug discovery and clinical trials

Major Challenge:

• Strict regulatory requirements for tissue handling and storage
• High costs associated with preservation and storage infrastructure
• Ethical concerns related to tissue donation and usage

Tissue Banking Market Segment-wise Analysis

By Tissue Type:

• Cardiac Tissues
• Orthopedic Tissues
• Skin Tissues
• Corneal Tissues
• Others

Orthopedic tissues dominate the market with approximately 36% share, driven by the rising number of bone-related disorders and trauma cases. Increasing incidences of fractures, joint replacements, and sports injuries have significantly boosted demand for bone grafts. More than 2.2 million bone graft procedures are performed annually worldwide, highlighting strong demand. Aging populations and increasing osteoporosis prevalence further support the adoption of preserved bone tissues across healthcare systems.

By Application:

• Research
• Therapeutics
• Drug Discovery
• Regenerative Medicine

Therapeutics segment leads the market, accounting for nearly 40% of total revenue. This growth is driven by the increasing use of tissue-based therapies in transplantation, wound healing, and reconstructive procedures. Hospitals rely heavily on tissue banks for timely access to high-quality tissues. Advancements in regenerative medicine and surgical techniques are further expanding therapeutic applications, strengthening segment dominance.

Regional Projection of Tissue Banking Industry

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

North America dominates the market with around 39% share due to advanced healthcare infrastructure and strong regulatory frameworks. The United States leads with widespread adoption of tissue banking technologies and strong presence of leading biotechnology companies.

Tissue Banking Market Recent Developments 

• 2025: Thermo Fisher Scientific Inc. expanded its biobanking and cryopreservation solutions portfolio to enhance biological sample storage and research efficiency across global laboratories.
   
• 2025: Lonza Group AG strengthened its cell and gene therapy capabilities, including tissue processing technologies supporting regenerative medicine and biobanking applications.
   
• 2025: BioLife Solutions Inc. advanced its biopreservation media and storage technologies to improve tissue viability during transportation and long-term storage.
   
• 2025: Merck KGaA enhanced its life sciences segment with expanded tissue preservation and biobanking solutions for pharmaceutical research and drug development.
   
• 2025: Charles River Laboratories expanded its tissue sourcing and biobanking services through strategic collaborations to support preclinical and clinical research programs.

Why Choose This Report?

• Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
• Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
• Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
• Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
• Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
• Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
• Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
• Provides valuable information based on actual customer data & search trends.